Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: A case-control study

Indian Journal of Gastroenterology

Volumn 33, Issue 1, 2014, Pages 12-18

  Patil, Prachi S ^a   Mohandas, K M ^b   Bhatia, Shobna J ^c   Mehta, Shaesta A ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b Tata Medical Centre   (India)

^c KEM HOSPITAL   (India)

Author keywords

Epidemiology; Iron deficiency; Liver cancer; Prevention; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; FERRITIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IRON DEFICIENCY; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORBIDITY; PREVALENCE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK FACTOR; SMOKING; VIRUS ETIOLOGY; VIRUS HEPATITIS;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; FERRITINS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; INDIA; IRON; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK; RISK FACTORS;

EID: 84893436400     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0367-5     Document Type: Article

References (31)

1. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13: 607-15.
2. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336: 1855-9.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1. 2, Cancer incidence and mortality worldwide: IARC cancer base no. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan. iarc. fr. Accessed 23 Apr 2013.
4. Villa E, Fattovich G, Mauro A, Pasino M. Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. Dig Liver Dis. 2011;43: S8-14.
5. Peng LH, Ling C, Yew CK, Aizen J, Yun LE, Ho W. Singapore cancer registry interim annual registry report. Trends in cancer incidence in Singapore 2006-2010. http://www. nccs. com. sg/pat/file/Cancer_Trends_Report_2006_2010. pdf. Accessed 2 May 2012.
6. Jain RV, Mills PK, Parikh-Patel A. Cancer incidence in the south Asian population of California, 1988-2000. J Carcinog. 2005;4: 21.
7. Swerdlow AJ, Marmot MG, Grulich AE, Head J. Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales. Br J Cancer. 1995;72: 1312-9.
8. Hann HW, Kim CY, London WT, Blumberg BS. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer. 1989;43: 376-9.
9. Kowdley KV. Iron, haemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004;127: S79-86.
10. Marrogi AJ, Khan MA, van Gijssel HE, et al. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. J Natl Cancer Inst. 2001;93: 1652-5.
11. Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassemia syndromes. Br J Haematol. 2004;124: 114-7.
12. Mandishona E, MacPhail AP, Gordeuk VR, et al. Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans. Hepatology. 1998;27: 1563-6.
13. Sartori M, Andorno S, Rossini A, et al. Phlebotomy improves histology in chronic hepatitis C males with mild iron overload. World J Gastroenterol. 2010;16: 596-602.
14. Kato J, Miyanishi K, Kobune M, et al. Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol. 2007;42: 830-6.
15. Kapur D, Agarwal KN, Agarwal DK. Nutritional anaemia and its control. Indian J Pediatr. 2002;69: 607-16.
16. Toteja GS, Singh P, Dhillon BS, et al. Prevalence of anemia among pregnant women and adolescent girls in 16 districts of India. Food Nutr Bull. 2006;27: 311-5.
17. WHO. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and mineral nutrition information system. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11. 2). http://www. who. int/vmnis/indicators/serum_ferritin. pdf. Accessed 23 April 2013.
18. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35: 421-30.
19. Dean AG, Arner TG, Sunki GG, et al. Epi Info™, a database and statistics program for public health professionals. Atlanta: CDC; 2011.
20. Lambrecht RW, Sterling RK, Naishadham D, et al. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology. 2011;140: 1490-500.
21. Lange CM, Kutalik Z, Morikawa K, et al. Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology. 2012;55: 1038-47.
22. Kowdley KV, Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55: 77-85.
23. Sartori M, Andorno S, Rossini A, et al. A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 2011;23: 1178-84.
24. Valenti L, Fracanzani AL, Dongiovanni P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007;102: 1251-8.
25. Sebastiani G, Tempesta D, Alberti A. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. J Viral Hepat. 2012;19: e170-6.
26. Nakano S, Kumada T, Sugiyama K, Watahiki H, Takeda I. Clinical significance of serum ferritin determination for hepatocellular carcinoma. Am J Gastroenterol. 1984;79: 623-7.
27. Uchino K, Tateishi R, Nakagawa H, et al. Serum ferritin level and risk of liver cancer development in patients with chronic liver diseases. Gastroenterology. 2011;140: S-925.
28. Yamasaki T, Terai S, Sakaida I. Deferoxamine for advanced hepatocellular carcinoma. N Engl J Med. 2011;365: 576-8.
29. Weismüller TJ, Kirchner GI, Scherer MN, et al. Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival. Hepatology. 2011;54: 2114-24.
30. Walker NM, Stuart KA, Ryan RJ, et al. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology. 2010;51: 1683-91.
31. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007;132: 1740-5.